| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |